Summary
This paper reviews roscovitine as a drug candidate for cystic fibrosis, focusing on TRP channel function and immune modulation. It has no relevance to lighting, circadian rhythms, or any of the target categories for this database.
Author(s)
E Jong
Publication Year
2010